| Year |
Citation |
Score |
| 2019 |
Harris PA, Faucher N, George N, Eidam PM, King BW, White G, Anderson NA, Bandyopadhyay D, Beal AM, Beneton V, Berger SB, Campobasso N, Campos S, Capriotti CA, Cox JA, et al. Discovery and Lead-optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase. Journal of Medicinal Chemistry. PMID 31013427 DOI: 10.1021/Acs.Jmedchem.9B00318 |
0.653 |
|
| 2017 |
Harris PA, Berger SB, Jeong JU, Nagilla R, Bandyopadhyay D, Campobasso N, Capriotti CA, Cox JA, Dare L, Dong X, Eidam PM, Finger JN, Hoffman SJ, Kang J, Kasparcova V, et al. Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. PMID 28151659 DOI: 10.1021/Acs.Jmedchem.6B01751 |
0.671 |
|
| 2014 |
Rickard DJ, Sehon CA, Kasparcova V, Kallal LA, Haile PA, Zeng X, Montoute MN, Poore DD, Li H, Wu Z, Eidam PM, Emery JG, Marquis RW, Gough PJ, Bertin J. Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathway. Plos One. 9: e96737. PMID 24806487 DOI: 10.1371/journal.pone.0096737 |
0.677 |
|
| 2013 |
Rickard DJ, Sehon CA, Kasparcova V, Kallal LA, Zeng X, Montoute MN, Chordia T, Poore DD, Li H, Wu Z, Eidam PM, Haile PA, Yu J, Emery JG, Marquis RW, et al. Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway. Plos One. 8: e69619. PMID 23936340 DOI: 10.1371/Journal.Pone.0069619 |
0.67 |
|
| 2011 |
Morales-Ramos ÃI, Li YH, Hilfiker M, Mecom JS, Eidam P, Shi D, Tseng PS, Brooks C, Zhang D, Wang N, Jaworski JP, Morrow D, Fries H, Edwards R, Jin J. Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21: 2806-11. PMID 21514150 DOI: 10.1016/j.bmcl.2011.03.107 |
0.628 |
|
| 2010 |
Jin J, Morales-Ramos A, Eidam P, Mecom J, Li Y, Brooks C, Hilfiker M, Zhang D, Wang N, Shi D, Tseng PS, Wheless K, Budzik B, Evans K, Jaworski JP, et al. Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists. Acs Medicinal Chemistry Letters. 1: 316-20. PMID 24900213 DOI: 10.1021/ml100077x |
0.624 |
|
| 2008 |
Marshall JA, Eidam PM. A formal synthesis of the callipeltoside aglycone. Organic Letters. 10: 93-6. PMID 18052287 DOI: 10.1021/ol702024b |
0.397 |
|
| 2007 |
Marshall J, Herold M, Eidam H, Eidam P. Pd- and Cu-Catalyzed 1,4-Addition of Dialkylzinc Compounds to α,β-Enals Synfacts. 2007: 0197-0197. DOI: 10.1055/s-2006-955806 |
0.698 |
|
| 2007 |
Marshall JA, Eidam P, Eidam HS. Synthesis of 4‐Triisopropylsilyl‐3‐Butyn‐2‐ol by Asymmetric Transfer Hydrogenation Organic Syntheses. 120-128. DOI: 10.1002/0471264229.Os084.12 |
0.711 |
|
| 2007 |
Marshall JA, Eidam P, Eidam HS. Synthesis of 4-triisopropylsilyl-3-butyn-2-ol by asymmetric transfer hydrogenation Organic Syntheses. 84: 120-128. |
0.699 |
|
| 2006 |
Marshall JA, Herold M, Eidam HS, Eidam P. Palladium- and copper-catalyzed 1,4-additions of organozinc compounds to conjugated aldehydes. Organic Letters. 8: 5505-8. PMID 17107058 DOI: 10.1021/Ol062154A |
0.717 |
|
| 2006 |
Marshall JA, Eidam P, Eidam HS. (R)- and (S)-4-TIPS-3-butyn-2-ol. Useful precursors of chiral allenylzinc and indium reagents. The Journal of Organic Chemistry. 71: 4840-4. PMID 16776511 DOI: 10.1021/Jo060542K |
0.72 |
|
| 2006 |
Marshall J, Eidam P, Eidam H. Chiral Allenylzinc and Indium Reagents for Asymmetric Propargylation Synfacts. 2006: 0941-0941. DOI: 10.1055/s-2006-949218 |
0.702 |
|
| 2004 |
Marshall JA, Eidam P. Diastereoselective additions of chiral vinylzinc reagents to alpha-chiral aldehydes. Organic Letters. 6: 445-8. PMID 14748614 DOI: 10.1021/Ol0363568 |
0.379 |
|
| Show low-probability matches. |